Singapore markets closed

Valerio Therapeutics Société anonyme (C4X.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.1140+0.0140 (+14.00%)
At close: 09:41PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-20,344
-20,344
-19,562
-5,937
1,089
Depreciation & amortisation
1,743
1,743
-167
511
-8,215
Stock-based compensation
514
514
724
224
79
Change in working capital
959
-665
6,875
-4,136
886
Other working capital
-18,780
-18,780
-9,931
-8,711
-4,797
Other non-cash items
139
139
2,402
666
669
Net cash provided by operating activities
-18,597
-18,597
-9,443
-8,572
-4,678
Cash flows from investing activities
Investments in property, plant and equipment
-26
-183
-488
-139
-119
Sales/maturities of investments
163
7
80
73
4
Other investing activities
-1
-1
-1
-
-
Net cash used for investing activities
-177
-177
-409
-66
6,015
Net change in cash
-7,771
-7,771
-3,301
3,363
8,815
Cash at beginning of period
14,585
14,585
17,886
14,523
5,708
Cash at end of period
6,814
6,814
14,585
17,886
14,523
Free cash flow
Operating cash flow
-18,597
-18,597
-9,443
-8,572
-4,678
Capital expenditure
-26
-183
-488
-139
-119
Free cash flow
-18,780
-18,780
-9,931
-8,711
-4,797